ZAMBON, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.902
EU - Europa 5.577
AS - Asia 5.326
SA - Sud America 770
AF - Africa 136
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.726
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.665
SG - Singapore 1.653
IT - Italia 1.575
CN - Cina 1.205
GB - Regno Unito 1.079
HK - Hong Kong 965
DE - Germania 774
SE - Svezia 640
BR - Brasile 583
VN - Vietnam 551
PL - Polonia 277
BD - Bangladesh 239
FR - Francia 238
RU - Federazione Russa 221
FI - Finlandia 196
UA - Ucraina 162
KR - Corea 156
CA - Canada 126
IN - India 121
ID - Indonesia 90
BG - Bulgaria 76
NL - Olanda 73
TR - Turchia 70
MX - Messico 65
AR - Argentina 56
IE - Irlanda 47
JP - Giappone 43
ES - Italia 40
BE - Belgio 37
EC - Ecuador 37
IQ - Iraq 33
ZA - Sudafrica 33
CO - Colombia 32
MA - Marocco 31
AT - Austria 29
MY - Malesia 28
AE - Emirati Arabi Uniti 23
VE - Venezuela 21
PK - Pakistan 20
IR - Iran 18
CH - Svizzera 16
EG - Egitto 15
LT - Lituania 14
TH - Thailandia 14
CL - Cile 13
RO - Romania 13
UZ - Uzbekistan 13
DZ - Algeria 12
KE - Kenya 12
PH - Filippine 12
CZ - Repubblica Ceca 11
PY - Paraguay 11
TN - Tunisia 11
SA - Arabia Saudita 9
AU - Australia 8
IL - Israele 8
PE - Perù 8
PT - Portogallo 8
BY - Bielorussia 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
GE - Georgia 7
HU - Ungheria 6
JM - Giamaica 6
JO - Giordania 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
DK - Danimarca 5
ET - Etiopia 5
LK - Sri Lanka 5
NP - Nepal 5
RS - Serbia 5
AL - Albania 4
BO - Bolivia 4
KZ - Kazakistan 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
AO - Angola 3
EE - Estonia 3
HN - Honduras 3
KG - Kirghizistan 3
LU - Lussemburgo 3
OM - Oman 3
PA - Panama 3
SV - El Salvador 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
LV - Lettonia 2
MK - Macedonia 2
ML - Mali 2
NG - Nigeria 2
NI - Nicaragua 2
SI - Slovenia 2
Totale 22.696
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.111
Singapore 1.088
Fairfield 1.029
Ashburn 956
Hong Kong 940
Woodbridge 626
Southend 565
Chandler 560
Houston 496
Modena 471
San Jose 446
Ann Arbor 437
Nyköping 381
Seattle 381
Cambridge 376
Hefei 356
Frankfurt am Main 346
Wilmington 325
London 289
Warsaw 256
Beijing 247
Jacksonville 221
Dearborn 217
Council Bluffs 204
Ho Chi Minh City 185
Los Angeles 182
Helsinki 176
Dallas 154
The Dalles 148
Chicago 145
Hanoi 143
Seoul 135
New York 128
Berlin 106
Bologna 93
San Diego 86
Princeton 74
Reggio Emilia 74
Sofia 73
Bremen 72
Boardman 65
Eugene 64
Lauterbourg 63
Milan 63
Jakarta 61
Moscow 60
Buffalo 58
Salt Lake City 58
Orem 51
São Paulo 48
Munich 45
Dublin 42
Shanghai 39
Parma 33
Redondo Beach 33
Brussels 32
Formigine 32
Redwood City 31
Tokyo 31
Da Nang 30
Izmir 30
Rome 30
Toronto 30
Amsterdam 29
Atlanta 28
Montreal 28
Tampa 26
Stockholm 24
Chennai 22
Vancouver 22
Wimbledon 22
Bomporto 21
Denver 21
Rio de Janeiro 21
Brooklyn 20
Elk Grove Village 20
Kent 20
Turin 20
Falls Church 19
Norwalk 19
Phoenix 18
Mexico City 17
Newark 17
Nuremberg 17
Belo Horizonte 16
Johannesburg 16
Voghera 16
Des Moines 15
Guangzhou 15
Haiphong 15
Lappeenranta 15
Madrid 15
Paris 15
Columbus 14
Florence 14
Manchester 14
Guayaquil 13
Ottawa 13
Poplar 13
Tashkent 13
Totale 16.010
Salva come PNG Salva come JPEG
Nome #
1 - ( 5 - TERT - BUTYL - 2 - ARYL - PYRAZOL - 3 - YL ) . 3 - 12 - FLUORO - 4 - [ ( 3 - OXO - 4H - PYRIDO [ 2 . 3 - BJPYRAZIN - 8 - YL ) OXY | PHENYLJUREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER 973
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships 591
Chiral polycyclic ketones via desymmetrization of dihaloolefins 439
Potential of wickerhamomyces anomalus in glycerol valorization 429
Cytocompatibility of potential bioactive cerium-doped glasses based on 45S5 390
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma 369
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling 362
Nucleoside 2’,3’-cyclic monophosphates in Aphanizomenon flos-aquae detected through nuclear magnetic resonance and mass spectrometry 345
A novel mechanism for the fluxional behaviour of [Pd(η2-tetramethylethylenetetracarboxylate)(2-methylthiomethylpyridine)] 339
A novel protocol for the one-pot borylation/Suzuki reaction provides easy access to hinge-binding groups for kinase inhibitors 338
A novel, selective, and efficacious nanomolar pyridopyrazinone inhibitor of V600EBRAF 331
Cerium Containing Bioactive Glasses: A Review 325
Abstract 3704: Novel panRAF inhibitors active in melanomas that are resistant to BRAF-selective, or BRAF-selective/MEK inhibitor combinations 323
BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ring 323
Characterization of compound 584, an Abl kinase inhibitor with lasting effects 321
Mesoporous bioactive glasses doped with cerium: Investigation over enzymatic-like mimetic activities and bioactivity 316
Assessment of chloroaniline toxicity by the submitochondrial particle assay 311
Development of novel, highly potent inhibitors of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF): Increasing cellular potency through optimization of a distal heteroaromatic group 310
BRAF as a therapeutic target: A patent review (2006-2012) 310
Structure Model and Toxicity of the Product of Biodissolution of Chrysotile Asbestos in the Lungs 306
Boosting sunscreen stability: New hybrid materials from UV filters encapsulation 303
Investigation on the antimicrobial properties of cerium-doped bioactive glasses 300
Novel hinge binder improves activity and pharmacokinetic properties of BRAF inhibitors 297
β-Glucuronidase Pattern Predicted From Gut Metagenomes Indicates Potentially Diversified Pharmacomicrobiomics 291
Ce-MBGs Loaded with Gentamicin: Characterization and In Vitro Evaluation 280
Development and exploitation of CK2 inhibitors 278
The discovery of novel, highly potent inhibitors of BRAF 277
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy 275
Synthesis and evaluation of new chiral diols based on the dicyclopentadiene skeleton 269
Tris-annelated benzenes selectively perfunctionalized on one side only: Hexachlorobenzotrinorbornadiene as a versatile scaffold for the construction of molecular domes 256
Novel Potent BRAF Inhibitors: Toward 1 nM Compounds through Optimization of the Central Phenyl Ring 255
"Hexacarboxytrindanes": Benzene rings with homotopic faces as scaffolds for the construction of D3 chiral architectures 251
Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors 249
Non canonical Cyclic Nucleotides Monophosphates in Aphanizomenon flosaquae: nuclear magnetic resonance and mass spectrometry 249
Study on the toxicity of phenolic and phenoxy herbicides using the submitochondrial particle assay 246
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors 244
Potent BRAF kinase inhibitors based on 2,4,5-trisubstituted imidazole with naphthyl and benzothiophene 4-substituents 244
Bifunctional mesoporous glasses for bone tissue engineering: Biological effects of doping with cerium and polyphenols in 2D and 3D in vitro models 243
Substituted aniline interaction with submitochondrial particles and quantitative structure-activity relationships 240
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds 238
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF) 237
Efficient access to 5-substituted thiazoles by a novel metallotropic rearrangement 235
Topical 5-Fluorouracil Elicits Regressions of BRAF Inhibitor–Induced Cutaneous Squamous Cell Carcinoma 234
1-(5-TERT-BUTYL-2-ARYL-PYRAZOL-3-YL)-3-2-FLUORO-4-(3-OXO-4H-PYRIDO2,3-BPYRAZIN-8-YL)OXYPHENYLUREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER 232
Surface acidity modifications induced by thermal treatments and acid leaching on microcrystalline H-BEA zeolite. A FTIR, XRD and MAS-NMR study 231
Internal motions in a fulleropyrrolidine tertiary amide with axial chirality 230
Gatekeeper mutations mediate resistance to BRAF-targeted therapies 230
Synthesis of the syn and anti isomer of 1,4,5,8,9,12-hexahydro-2,3,6,7,10,11-hexamethylidene-1,4 : 5,8 : 9,12-trimethanotriphenylene and Diels-Alder reactivity of the syn isomer 229
Loading with Biomolecules Modulates the Antioxidant Activity of Cerium-Doped Bioactive Glasses 228
Isolation and characterization of all eight bisadducts of fulleropyrrolidine derivatives 227
Novel oligothiophenes with reduced HOMO-LUMO band gap for Optoelectonics 227
Synthesis and evaluation of antiparasitic activities of new 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine derivatives 222
Small molecule inhibitors of BRAF in clinical trials 220
ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF 219
Nucleophilic reactions at the ring carbons of thiiranium and thiirenium ions. An experimental and theoretical comparison of the S(N)2 and S(N)2-Vin mechanisms 217
Efficient cyclotrimerization of bicyclic vic-bromostannylalkenes promoted by copper(I) thiophen-2-carboxylate 211
Dual Kinase Targeting in Leukemia 210
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma 203
ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF 201
Qualitative and quantitative discrimination of fake and true alkene rotation processes in pd(η2-olefin) complexes. A new bimolecular mechanism 201
Expedient Access to Type II Kinase Inhibitor Chemotypes by Microwave-Assisted Suzuki Coupling 201
Cytocompatibility of mesoporous bioactive glasses doped with cerium and loaded with polyphenols 197
Evaluation of the Properties of Bioactive Mesoporous Glasses Doped with Cerium and Loaded with Polyphenols 192
Biostimulants derived from organic urban wastes and biomasses: An innovative approach 191
Non-canonical Cyclic Nucleoside Monophosphates in Aphanizomenon flos-aquae: nuclear magnetic resonance and mass spectrometry 190
Erratum: Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase (ACS Omega (2022) 7:20 (17083-17097) DOI: 10.1021/acsomega.2c00507) 174
Synthetic approach to novel NMP/ALK inhibitors 173
Toward the Scale-Up of a Bicyclic Homopiperazine via Schmidt Rearrangement and Photochemical Oxaziridine Rearrangement in Continuous-Flow 171
α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML 170
Double-ion doped mesoporous glasses: Studies on stability, antibacterial and antioxidant properties, and bioactivity 169
Extraction, purification and in vitro assessment of the antioxidant and anti-inflammatory activity of policosanols from non-psychoactive Cannabis sativa L. 168
Evaluation of the behaviour of hydrogels containing mesoporous glasses doped with cerium and loaded with polyphenols 165
Paradoxical activation of the MEK/ERK pathway promotes melanoma invasion and metastasis 164
NON CANONICAL CYCLIC NUCLEOTIDES MONOPHOSPHATES IN APHANIZOMENON FLOS-AQUAE: NUCLEAR MAGNETIC RESONANCE AND MASS SPECTROMETRY 162
Rational design of inhibitors of the anaplastic lymphoma kinase 161
endo-1-Phenylborneol as a novel, alternative chiral auxiliary for the aza-Diels-Alder reaction 160
Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinase 157
LYSYL OXIDASE INHIBITORS 155
Dual loaded Ce-MBGs with bioactivity, antioxidant and antibacterial properties 152
Novel ligands from direct benzylic functionalisation of tris(2-pyridylmethyl)amine 146
Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase 146
Preparation of 1-​(5-​tert-​butyl-​2-​aryl-​pyrazol-​3-​yl)​-​3-​[2-​fluoro-​4-​[(3-​oxo-​4H-​pyrido[2,​3-​b]​pyrazin-​8-​yl)​oxy]​phenyl]​urea derivatives as RAF inhibitors for treating cancer 140
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers 137
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 132
Erratum: Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006)) 124
Long-term durability of discarded cork-based composites obtained by geopolymerization 117
Corrections to pyridoimidazolones as novel potent inhibitors of v-raf murine sarcoma viral oncogene homologue B1 (BRAF) (Journal of Medicinal Chemistry (2009) 52, (2255-2256) DOI: 10.1021/jm801509w) 115
Polyphosphate coacervate gels for manufacturing of manganese loaded glass powders and fibres: structural, cytocompatibility and surface bioactivity study 114
PROCESS FOR THE PREPARATION OF 8-(4-AMINOPHENOXY)-4H PYRIDO2,3-B PYRAZIN-3-ONE DERIVATIVES 105
Erratum: Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinoma (Journal of Investigative Dermatology (2013) 133 (274-276) DOI: 10.1038/jid.2012.268;0 102
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 100
Dual-functional cerium-containing mesoporous bioactive glasses for drug delivery 97
Enhanced bone regeneration with cerium-doped bioactive glasses: In vitro and in vivo study 96
Gelatin/Cerium-Doped Bioactive Glass Composites for Enhancing Cellular Functions of Human Mesenchymal Stem Cells (hBMSCs) 87
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 87
Targeting monocarboxylate transporter 1 with a copper-chelating coumarin-based bioconjugate: Synthesis and characterization 82
Materiale fotoassorbente ad ampio spettro, procedimento per la sua preparazione ed usi relativi 74
Negative Allosteric Modulators of A2AR: A New Weapon for Cancer Immunotherapy? 69
Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia 63
Totale 22.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021117 0 0 0 0 0 0 0 0 0 0 0 117
2021/20221.642 91 208 200 57 73 89 98 81 185 92 283 185
2022/20231.939 242 215 133 183 255 245 70 171 244 45 76 60
2023/20241.604 51 94 109 93 508 43 276 177 43 46 51 113
2024/20254.005 124 43 122 200 799 559 210 316 561 222 391 458
2025/20268.130 419 321 687 891 1.053 979 869 408 719 754 629 401
Totale 22.885